• Aucun résultat trouvé

Answer: Can you identify this condition?

N/A
N/A
Protected

Academic year: 2022

Partager "Answer: Can you identify this condition?"

Copied!
1
0
0

Texte intégral

(1)

384

Canadian Family PhysicianLe Médecin de famille canadien Vol 55: april • aVril 2009

Ophthaproblem

Answer to Ophthaproblem

continued from page 383

4. Postoperative endophthalmitis

Postoperative endophthalmitis (PE) is a potentially dev- astating complication of ophthalmic surgery and is char- acterized by infection and inflammation of the eye. It occurs most frequently after cataract surgery, with an incidence of approximately 0.05%.1 Awareness of the condition is important—delay in diagnosis can result in permanent blindness.

Most commonly, PE presents acutely in the first 2 weeks following surgery. Patients typically report symp- toms such as a red eye, pain, decreased vision, and discharge in the affected eye, all of which might be rap- idly progressive.2 Headache and photophobia might also occur. Common clinical signs seen during examination include decreased visual acuity (often severe), swelling of the eyelid, conjunctival and corneal edema, hypo- pyon, anterior chamber cells and flare, a blunted red reflex, blurred view of retinal vessels on ophthalmos- copy, and vitreous and retinal inflammation.2,3

Most cases of PE are thought to occur because of introduction of the patient’s normal periocular flora into the eye during surgery. Gram-positive bacteria are iso- lated in more than 90% of cases, with the most common species being coagulase-negative staphylococci.3,4 Other frequently isolated bacteria include Staphylococcus aureus, streptococcus species, and Gram-negative bacteria; however, these are typically associated with worse prognoses.3 Fungal endophthalmitis is exceed- ingly rare and typically presents weeks to months after surgery, although it too can present in the first few days postoperatively.5

Management

Endophthalmitis should be suspected in any eye with inflammation greater than expected in the postopera- tive period.2 Immediate referral to the ophthalmologist who performed the surgery is imperative. The manage- ment strategy will then be directed according to the presenting visual acuity in the affected eye. If vision is better than light perception, aqueous and vitreous samples should be obtained with both an aqueous tap and either a vitreous tap or a vitreous biopsy (with a cutting and aspiration probe).3 Samples are sent for Gram stain, culture, and sensitivity. Empiric antibiotics are then administered, usually in the form of a single intravitreal injection of vancomycin and ceftazidime.2 Patients should be closely followed up and if no clinical improvement is seen within 48 hours, a repeat injection might be warranted (although the risk of retinal toxicity should be considered).2

For patients presenting with a visual acuity of light perception only or worse, the Endophthalmitis Vitrectomy Study Group showed an improved outcome with immediate vitrectomy.3 Vitrectomy not only allows for collection of samples, but also has other benefits, including improvement of antibiotic distribution and reduction of infecting organisms, toxins, and opacities.2 Antibiotics are administered at the time of surgery.

The prognosis of PE is variable and depends on the type of organism isolated as well as the degree of inflammatory damage to the eye. Outcomes range from excellent visual acuity to blindness and even loss of the eye altogether.

Recommendations

Postoperative endophthalmitis must be considered for any patient complaining of substantial pain, redness, or decreased vision following cataract surgery. Urgent referral to the cataract surgeon is necessary.

Mr Johnson is a third-year medical student at Queen’s University in Kingston, Ont. Dr Sharma is an Associate Professor in the Department of Ophthalmology at Queen’s University.

Competing interests None declared references

1. Miller JJ, Scott IU, Flynn HW Jr, Smiddy WE, Newton J, Miller D. Acute- onset endophthalmitis after cataract surgery (2000-2004): incidence, clini- cal settings, and visual acuity outcomes after treatment. Am J Ophthalmol 2005;139(6):983-7.

2. Lemley CA, Han DP. Endophthalmitis: a review of current evaluation and management. Retina 2007;27(6):662-80. Erratum in: Retina 2007;27(7):TOC.

3. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intrave- nous antibiotics for the treatment of postoperative bacterial endophthalmitis.

Arch Ophthalmol 1995;113(12):1479-96.

4. Lalwani GA, Flynn HW Jr, Scott IU, Quinn CM, Berrocal AM, Davis JL, et al. Acute-onset endophthalmitis after clear corneal cataract surgery (1996- 2005). Clinical features, causative organisms, and visual acuity outcomes.

Ophthalmology 2008;115(3):473-6. Epub 2007 Dec 11.

5. Narang S, Gupta A, Gupta V, Dogra MR, Ram J, Pandav SS, et al. Fungal endophthalmitis following cataract surgery: clinical presentation, microbio- logical spectrum, and outcome. Am J Ophthalmol 2001;132(5):609-17.

✶ ✶ ✶

Références

Documents relatifs

5 Fixed drug eruption has a favourable prognosis com- pared with other bullous skin eruptions such as Stevens- Johnson syndrome and toxic epidermal necrolysis.. The

TYPE OF HYPERLiPiDEMiA COnDiTiOn TYPE OF XAnTHOMAS TRigLYCERiDE LEVELS CHOLESTEROL LEVELS ELEVATED LiPOPROTEin..

3 Differential diagnoses include benign eyelid masses (eg, seborrheic keratosis, cysts, nevi, hordeolum, chalazia, mulluscum contagiosum, actinic keratosis, and squa-

Inverse psoriasis mimics many intertriginous skin erup- tions; these include common conditions, such as inter- triginous cutaneous candidiasis and dermatophytosis, and less

Idiopathic intracranial hypertension (IIH), also known as pseudotumour cerebri or benign intracranial hyper- tension, is a neurologic disorder characterized by

11 A patient who has many DN, or a DN and a personal or family history of melanoma, is at increased risk of developing melanoma and should be periodically

First described in 1988, pal- moplantar eccrine hidrade- nitis (PEH) is an uncommon, benign, self-limiting, dis- tinctive entity that usually affects healthy children

2,3 Symptoms are usually limited to the skin and manifest as strikingly large (ie, 0.5 to 4 cm in diameter) purpuric skin lesions in a targetlike pattern and marked edema of the